// App-Quantinova.ai

: Sotagliflozin Reduces Glucose Variability and Risk for Hyperglycemia in Adults with Type 1 Diabetes

Researchers

Presenter

  • BORIS KOVATCHEV

Principal Investigators

  • STELLA WANG

  • JULIANA H. OLIVEIRA

  • JOHN A. STEWART

  • PABLO LAPUERTA

Medical Centers

  • N/A

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Hyperglycemia

  • Diabetes

Biomarkers

  • Hemoglobin A1c

  • Solute Carrier Family 5 Member 1

Drug/Treatment

  • LX4211

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved